Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes.

ABSTRACT: BACKGROUND:A chronic disease impacts a patient's daily life, with the burden of symptoms and managing the condition, and concerns of progression and disease complications. Such aspects are captured by Patient-Reported Outcomes Measures (PROM), assessments of e.g. wellbeing. Patient-Reported Experience Measures (PREM) assess patients' experiences of healthcare and address patient preferences. Biomarkers are useful for monitoring disease activity and treatment effect and determining risks of progression and complications, and they provide information on current and future health. Individuals may differ in which among these aspects they consider important. We aimed to develop a measure of quality of life using biomarkers, PROM and PREM, that would provide an unambiguous ranking of individuals

SUBMITTER: Borg S 

PROVIDER: S-EPMC6836539 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature